000 | 01070cam a2200253 a 4500 | ||
---|---|---|---|
001 | vtls003210529 | ||
003 | MY-SjTCS | ||
005 | 20200226114420.0 | ||
008 | 110218s2008 fluaf b 001 0 eng | ||
020 | _a9780849327995 (hbk.) | ||
020 | _a0849327997 (hbk.) | ||
039 | 9 |
_a201305161130 _bVLOAD _c201102181515 _dVLOAD _c201010061720 _dpushpa _y201009201347 _zmalathy |
|
082 | 0 | 4 |
_a616.994061 _bANT 2008 |
245 | 0 | 0 |
_aAntiangiogenic cancer therapy / _cedited by Darren W. Davis, Roy S. Herbst, James L. Abbruzzese. |
260 |
_aBoca Raton : _bCRC Press, _cc2008. |
||
300 |
_a841 p., [16] p. of plates : _bill. ; _c27 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 2 | _aAngiogenesis in cancer -- Targeting angiogenesis for cancer therapy -- Translating angiogenesis inhibitors to the clinic -- Treatment of specific cancers with angiogenesis inhibitors. | |
650 | 0 |
_aNeovascularization inhibitors. _946857 |
|
700 | 1 |
_aDavis, Darren W., _d1971- |
|
700 | 1 | _aHerbst, Roy. | |
700 | 1 | _aAbbruzzese, James L. | |
920 | _aPHA : 151901 | ||
999 |
_c132043 _d132043 |